Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleBreast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling.AuthorsManuela Campiglio; Mario Mancino; Marianna Gallo; Amelia D’Alessio; Sylvie MenardPublicationBreast Cancer Research & Treatment, 2008, Vol 112, Issue 1, p25ISSN0167-6806Publication typeArticle